as on September 18, 2025 at 12:03 pm IST
Market Cap
₹3,497.12 Cr
Return on Equity (ROE)
19.44
PE Ratio (TTM)
56.79
Return on capital employed (ROCE)
24.14
Industry PE ratio
52.3
Beta (LTM)
0.77
P/B Ratio
5.87
Dividend Yield
0PEG Ratio
11.43
Quarterly Earnings Growth YOY
53.83
EPS (TTM)
9.25
Sector
Healthcare
Book Value
72.1
Technical Analysis
Bullish
View Technical Analysis
as on September 18, 2025 at 12:03 pm IST
Vimta Labs in the last 5 years
Lowest (13.76x)
March 20, 2023
Industry (52.30x)
September 17, 2025
Today (56.79x)
September 17, 2025
Highest (63.45x)
September 5, 2025
Today’s Price to Earnings Ratio: 56.79x
Compare market cap, revenue, PE, and other key metrics of Vimta Labs with its industry peers.
Company | Analyst View | Market Cap(in ₹ Cr) | 5 Year CAGR | Debt to Asset Ratio | Net Profit(in ₹ Cr) | Yearly Revenue(in ₹ Cr) |
---|---|---|---|---|---|---|
NA | 3,497.12 | 249.12% | 0.00 | 41 | 318 | |
NA | 100.16 | 14.74% | 0.50 | 2 | 16 | |
NA | 52.64 | 44.32% | 0.00 | 5 | 16 | |
NA | 45.88 | -12.37% | 0.00 | 5 | 19 | |
NA | 46.43 | -10.47% | 0.51 | 1 | 59 |
Investment in Vimta Labs Ltd Shares on INDmoney has dropped by -31.69% over the past 30 days, indicating reduced transactional activity.
Time period: to
Search interest for Vimta Labs Ltd Stock has decreased by -16% in the last 30 days, reflecting a downward trend in search activity.
Time period: to
Figures in Rupees Crores
Figures in Rupees Crores
Figures in Rupees Crores
View detailed summary of the earnings and dividend history of Vimta Labs.
Vimta Labs Ltd’s net profit jumped 53.83% since last year same period to ₹18.89Cr in the Q1 2025-2026. On a quarterly growth basis, Vimta Labs Ltd has generated 3.11% jump in its net profits since last 3-months.
Read More about Earnings ResultsIn the quarter ending March 2025, Vimta Labs Ltd has declared dividend of ₹2.00 per share on 28 Apr 2025 - translating a dividend yield of 0.51%.
Read More about DividendsCheck stock indices that include Vimta Labs.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Rise
In the last 1 month, VIMTALABS stock has moved up by 18.2%
Best in 1 Year
In the last 1 year, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Revenue Rich
Revenue is up for the last 5 quarters, 75.57 Cr → 99.31 Cr (in ₹), with an average increase of 6.5% per quarter
Best in 3 Years
In the last 3 years, VIMTALABS has outperformed top 5 stocks with highest market-cap in Biotechnology & Medical Research
Retail Holding Up
Retail Investor have increased holdings from 58.20% to 58.42% in Jun 2025 quarter
Profit Spike
Netprofit is up for the last 3 quarters, 12.28 Cr → 21.5 Cr (in ₹), with an average increase of 24.3% per quarter
Promoter Holding Down
Promoters have decreased holdings from 36.70% to 36.67% in Jun 2025 quarter
FII Holding Down
Foreign Institutions have decreased holdings from 3.66% to 3.49% in Jun 2025 quarter
Organisation | Vimta Labs Ltd |
Industry | Healthcare |
CEO | S P Vasireddi |
E-voting on shares | Click here to vote |
Vimta Labs share price today stands at ₹780.85 as on . Vimta Labs share today touched a day high of ₹789.9 and a low of ₹777.
Vimta Labs touched a 52 week high of ₹902.65 and a 52 week low of ₹251.53. Vimta Labs share price today i.e. is trending at ₹780.85, which is -13.49% down from its 52 week high and 210.44% up from its 52 week low.
Vimta Labs market capitalisation is ₹3,497.12 Cr as on .
To buy Vimta Labs shares, you need to follow these steps:
Vimta Labs trading volume is 2.31L as on . This means that 2.31L shares of Vimta Labs were bought and sold on the stock market during today's trading session.